BIOMAT Database Logo BIOMAT Database Logo

Modification of pyrimidine derivatives from antiviral agents to antitumor agents. 2006

Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
Department of Pharmaceutical Manufacturing Chemistry 21st Century COE program, Kyoto Pharmaceutical University, 1 Shichono-cho, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan.

2,4-Diaminopyrimidine derivatives, that were originally developed as antiviral agents, were modified to antitumor agents by: (i) introducing an amino group at C-5 on the pyrimidine ring, (ii) changing the alkyl group and the ring size of the cycloalkyl group on the beta-position of the omega-hydroxyalkylamino group, (iii) replacing the phenylalkyl group on the cycloalkyl group with the 3,4,5-trimethoxyphenylalkyl group, (iv) the esterification of the primary alcohol with diethyl phosphate and (v) introducing the thiomethyl group at C-2 on the pyrimidine ring. Among the 21 compounds prepared, 6, which has cyclobutyl at the beta-position, exhibited potent activity towards P-388 leukemia. In addition, 14, with methoxyl groups on the phenyl ring and 17, with the thiomethyl group on the pyrimidine ring, showed specific inhibition for the EGFR protein kinase. Moreover, 15 and 16, which carry the diethyl phosphoryl group on the primary alcohol, exhibited inhibitory activity towards P-glycoprotein.

UI MeSH Term Description Entries
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
Alkylated pyrimidine derivatives as antiviral agents. 3. Synthesis and antiviral effect of 5-ethyluracil nucleosides.
June 1973, Chemical & pharmaceutical bulletin,
Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
[Antiviral potentials. XI. Pyrimidine derivatives].
May 1969, Il Farmaco; edizione scientifica,
Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
Novel tetranuclear grid-like Zn(II) complexes derived from dihydrazone pyrimidine derivatives as antitumor agents.
January 2024, Dalton transactions (Cambridge, England : 2003),
Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
[New pyrimidine derivatives with antiviral activity].
January 1968, Il Farmaco; edizione scientifica,
Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
Alkylated pyrimidine derivatives as antiviral agents. I. Syntheses and antiviral screening of alkylpyrimidine and 5-alkyluracil nucleoside.
February 1970, Chemical & pharmaceutical bulletin,
Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
Lead optimization through VLAK protocol: new annelated pyrrolo-pyrimidine derivatives as antitumor agents.
September 2012, European journal of medicinal chemistry,
Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
Synthesis and biological evaluation of some quinazoline derivatives as antitumor and antiviral agents.
January 2003, Arzneimittel-Forschung,
Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
Antiviral Agents - Benzazine Derivatives.
January 2021, Chemistry of heterocyclic compounds,
Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
[From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents].
January 2007, Bulletin de l'Academie nationale de medecine,
Hiroyuki Kimura, and Takahiro Katoh, and Tetsuya Kajimoto, and Manabu Node, and Masakatsu Hisaki, and Yoshikazu Sugimoto, and Tetsuo Majima, and Yoshimasa Uehara, and Takao Yamori
Pyrazolo[3,4-d]pyrimidine derivatives containing a Schiff base moiety as potential antiviral agents.
September 2018, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!